These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1098 related items for PubMed ID: 28453482

  • 1. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Tan YJ, Ng ASL, Vipin A, Lim JKW, Chander RJ, Ji F, Qiu Y, Ting SKS, Hameed S, Lee TS, Zeng L, Kandiah N, Zhou J.
    J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
    [Abstract] [Full Text] [Related]

  • 2. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J, Marecek R, Klobusiakova P, Balazova Z, Anderkova L, Nemcova-Elfmarkova N, Rektorova I.
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [Abstract] [Full Text] [Related]

  • 3. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA, Pua EP, Zhou J, Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2015 Jan; 45(1):253-68. PubMed ID: 25524955
    [Abstract] [Full Text] [Related]

  • 4. Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression.
    Joko T, Washizuka S, Sasayama D, Inuzuka S, Ogihara T, Yasaki T, Hagiwara T, Sugiyama N, Takahashi T, Kaneko T, Hanihara T, Amano N.
    Psychogeriatrics; 2016 Nov; 16(6):355-361. PubMed ID: 26756596
    [Abstract] [Full Text] [Related]

  • 5. Grey-matter atrophy in Alzheimer's disease is asymmetric but not lateralized.
    Derflinger S, Sorg C, Gaser C, Myers N, Arsic M, Kurz A, Zimmer C, Wohlschläger A, Mühlau M.
    J Alzheimers Dis; 2011 Nov; 25(2):347-57. PubMed ID: 21422522
    [Abstract] [Full Text] [Related]

  • 6. Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy.
    Hagemeier J, Woodward MR, Rafique UA, Amrutkar CV, Bergsland N, Dwyer MG, Benedict R, Zivadinov R, Szigeti K.
    Psychiatry Res Neuroimaging; 2016 Sep 30; 255():87-93. PubMed ID: 27567325
    [Abstract] [Full Text] [Related]

  • 7. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
    Fleisher AS, Sun S, Taylor C, Ward CP, Gamst AC, Petersen RC, Jack CR, Aisen PS, Thal LJ.
    Neurology; 2008 Jan 15; 70(3):191-9. PubMed ID: 18195264
    [Abstract] [Full Text] [Related]

  • 8. DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease.
    Ozaki Y, Yoshino Y, Yamazaki K, Sao T, Mori Y, Ochi S, Yoshida T, Mori T, Iga JI, Ueno SI.
    J Psychiatr Res; 2017 Sep 15; 92():74-80. PubMed ID: 28412600
    [Abstract] [Full Text] [Related]

  • 9. Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment.
    Zhang H, Trollor JN, Wen W, Zhu W, Crawford JD, Kochan NA, Slavin MJ, Brodaty H, Reppermund S, Kang K, Mather KA, Sachdev PS.
    J Neurol Neurosurg Psychiatry; 2011 May 15; 82(5):487-93. PubMed ID: 21047881
    [Abstract] [Full Text] [Related]

  • 10. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
    Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM.
    Arch Neurol; 2006 May 15; 63(5):693-9. PubMed ID: 16682538
    [Abstract] [Full Text] [Related]

  • 11. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
    Jack CR, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, Knopman DS, Boeve BF, Klunk WE, Mathis CA, Petersen RC.
    Brain; 2008 Mar 15; 131(Pt 3):665-80. PubMed ID: 18263627
    [Abstract] [Full Text] [Related]

  • 12. The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume.
    Lupton MK, Strike L, Hansell NK, Wen W, Mather KA, Armstrong NJ, Thalamuthu A, McMahon KL, de Zubicaray GI, Assareh AA, Simmons A, Proitsi P, Powell JF, Montgomery GW, Hibar DP, Westman E, Tsolaki M, Kloszewska I, Soininen H, Mecocci P, Velas B, Lovestone S, Alzheimer's Disease Neuroimaging Initiative, Brodaty H, Ames D, Trollor JN, Martin NG, Thompson PM, Sachdev PS, Wright MJ.
    Neurobiol Aging; 2016 Apr 15; 40():68-77. PubMed ID: 26973105
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer's disease.
    Casati M, Ferri E, Gussago C, Mazzola P, Abbate C, Bellelli G, Mari D, Cesari M, Arosio B.
    Eur J Neurol; 2018 Jun 15; 25(6):805-810. PubMed ID: 29377401
    [Abstract] [Full Text] [Related]

  • 14. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Vipin A, Loke YM, Liu S, Hilal S, Shim HY, Xu X, Tan BY, Venketasubramanian N, Chen CL, Zhou J.
    Alzheimers Res Ther; 2018 Aug 18; 10(1):82. PubMed ID: 30121086
    [Abstract] [Full Text] [Related]

  • 15. TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer's disease hippocampus.
    Celarain N, Sánchez-Ruiz de Gordoa J, Zelaya MV, Roldán M, Larumbe R, Pulido L, Echavarri C, Mendioroz M.
    Clin Epigenetics; 2016 Aug 18; 8():37. PubMed ID: 27051467
    [Abstract] [Full Text] [Related]

  • 16. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.
    Luis EO, Ortega-Cubero S, Lamet I, Razquin C, Cruchaga C, Benitez BA, Lorenzo E, Irigoyen J, Alzheimer's Disease Neuroimaging Initiative (ADNI), Pastor MA, Pastor P.
    Neurobiol Aging; 2014 Dec 18; 35(12):2681-2690. PubMed ID: 25027412
    [Abstract] [Full Text] [Related]

  • 17. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.
    Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, Jack CR.
    Brain; 2007 Jul 18; 130(Pt 7):1777-86. PubMed ID: 17533169
    [Abstract] [Full Text] [Related]

  • 18. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA, Möller C, Dieleman N, Bouwman FH, Barkhof F, Scheltens P, van der Flier WM, Vrenken H.
    J Neurol Neurosurg Psychiatry; 2016 Apr 18; 87(4):425-32. PubMed ID: 25904810
    [Abstract] [Full Text] [Related]

  • 19. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
    Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, Vogel JW, Kramer JH, van der Vlies AE, La Joie R, Rosen HJ, van der Flier WM, Grinberg LT, Rozemuller AJ, Huang EJ, van Berckel BN, Miller BL, Barkhof F, Jagust WJ, Scheltens P, Seeley WW, Rabinovici GD.
    Brain; 2015 Sep 18; 138(Pt 9):2732-49. PubMed ID: 26141491
    [Abstract] [Full Text] [Related]

  • 20. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
    Vipin A, Foo HJL, Lim JKW, Chander RJ, Yong TT, Ng ASL, Hameed S, Ting SKS, Zhou J, Kandiah N.
    J Alzheimers Dis; 2018 Sep 18; 66(2):533-549. PubMed ID: 30320575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.